(MedPage Today) — BERLIN — Survival in high-risk bladder cancer improved significantly with use of circulating tumor (ct)DNA to guide adjuvant treatment in patients who tested positive after surgery, the randomized, placebo-controlled IMvigor011…
Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118072
Author :
Publish date : 2025-10-21 21:36:00
Copyright for syndicated content belongs to the linked Source.
